Amanote Research
Register
Sign In
Fragment-Based Discovery of 6Arylindazole JAK Inhibitors
doi 10.1021/acsmedchemlett.6b00087.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
Fragment-Based Discovery of Inhibitors of the Bacterial DnaG-SSB Interaction
Antibiotics
Pharmacology
Biochemistry
Microbiology
Toxicology
Infectious Diseases
Pharmaceutics
Discovery of Novel KRAS-PDE Inhibitors by Fragment-Based Drug Design
Discovery of Plasmepsin Inhibitors by Fragment-Based Docking and Consensus Scoring
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Fragment-Based Discovery of 6 Azaindazoles as Inhibitors of Bacterial DNA Ligase
Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Discovery of 2Indole-Acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods
Discovery of 2Indole-Acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods
